rTMS reduces fibromyalgia pain in women significantly

A recent study has found that repetitive transcranial magnetic stimulation (rTMS) can significantly reduce pain in women with fibromyalgia. The study involved 101 participants who received either active rTMS or sham stimulation over eight weeks. The results showed a high probability of at least a 50% reduction in pain intensity during this period. The participants, with an average age of 48, were selected because they did not respond to conventional treatments. Those receiving real rTMS experienced a greater reduction in pain compared to the sham group, with the effect lasting for up to 16 weeks in terms of functional improvements. Common side effects were similar between the two groups and included headaches and neck pain. Most participants reported no adverse effects. The researchers noted the study is significant because it’s the first multicenter trial to demonstrate the potential pain relief benefits of rTMS for fibromyalgia patients. The authors emphasized the need for more research to optimize treatment and personalize approaches for better results in the future. Overall, these findings add to the growing evidence supporting non-invasive brain stimulation as a viable option for managing fibromyalgia symptoms.